Valuation: Novogenia AG

Market Cap 7.8Cr 8.9Cr 7.21Cr 6.63Cr 13Cr 858.14Cr 13Cr 86Cr 34Cr 419.88Cr 33Cr 33Cr 1.45TCr P/E 2025
155x
P/E 2026 * -12.7x
Enterprise Value 2.19Cr 2.5Cr 2.02Cr 1.86Cr 3.51Cr 240.94Cr 3.57Cr 24Cr 9.49Cr 117.89Cr 9.38Cr 9.18Cr 406.16Cr EV / Sales 2025
0.85x
EV / Sales 2026 * 1.16x
Free-Float
42.5%
Yield 2025 *
6.23%
Yield 2026 * 6.62%
1 day+15.79%
Current month-7.69%
1 month-3.65%
3 months-25.00%
6 months-20.48%
Current year-15.92%
1 week 5.7
Extreme 5.7
6.65
1 month 5.7
Extreme 5.7
7.9
Current year 5.7
Extreme 5.7
12.1
1 year 5.5
Extreme 5.5
12.1
3 years 4.8
Extreme 4.8
12.1
5 years 4.8
Extreme 4.8
12.1
10 years 4.8
Extreme 4.8
12.1
Manager TitleAgeSince
Chief Executive Officer 43 15/03/2021
Director of Finance/CFO - -
Chief Investment Officer - 01/01/2023
Director TitleAgeSince
Chairman 63 23/06/2021
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+15.79%0.00% - - 8.9Cr
-0.49%-4.01%-0.84%+2.28% 4.87TCr
-3.10%-1.94%+370.99%+572.60% 3.84TCr
-0.46%+2.18%+5.44%+61.01% 3.45TCr
-1.14%-1.76%+26.94%-9.93% 3.4TCr
-1.82%-1.43%+0.52%+31.85% 2.68TCr
-3.54%-5.08% - - 1.56TCr
-1.82%-0.43%+69.28%+113.82% 1.51TCr
+1.17%+2.30%+15.87%+18.26% 1.42TCr
-2.25%+0.05%+15.77%-32.83% 1.27TCr
Average +0.23%-1.12%+63.00%+94.63% 2.67TCr
Weighted average by Cap. -1.41%-1.44%+74.77%+116.99%

Financials

2025 2026 *
Net sales 5.6Cr 6.39Cr 5.18Cr 4.76Cr 8.98Cr 616.16Cr 9.13Cr 62Cr 24Cr 301.48Cr 24Cr 23Cr 1.04TCr 5.72Cr 6.53Cr 5.29Cr 4.87Cr 9.18Cr 629.85Cr 9.33Cr 63Cr 25Cr 308.18Cr 25Cr 24Cr 1.06TCr
Net income 33L 37.65L 30.5L 28.05L 52.93L 36Cr 53.78L 3.65Cr 1.43Cr 18Cr 1.41Cr 1.38Cr 61Cr -61L -69.59L -56.39L -51.86L -97.85L -67Cr -99.42L -6.74Cr -2.64Cr -33Cr -2.61Cr -2.56Cr -113.13Cr
Net Debt -5.61Cr -6.4Cr -5.19Cr -4.77Cr -9Cr -617.2Cr -9.14Cr -62Cr -24Cr -301.99Cr -24Cr -24Cr -1.04TCr -1.16Cr -1.32Cr -1.07Cr -98.62L -1.86Cr -127.62Cr -1.89Cr -13Cr -5.03Cr -62Cr -4.97Cr -4.86Cr -215.14Cr
Logo Novogenia AG
Novogenia AG, formerly Darwin AG, is a Germany-based company, which operates as a biotechnology company. The Company is engaged in production and distribution of personalized dietary supplements and cosmetics. It offers Deoxyribonucleic Acid (DNA), genetic and blood analyses in the lifestyle segment. In addition, test results are primarily used to produce dietary supplements and cosmetics. The Company is active in Pharmaceutical and medical device trading segment as well. It uses artificial intelligence (AI) to create personalized solutions from scientific laboratory analysis data (personalized infusion therapies and In Vitro Fertilization (IVF)/reproductive genetics).
Employees
204
Date Price Change Volume
20/26/20 €6.600 +15.79% 100
17/26/17 €5.700 -9.52% 0
16/26/16 €6.300 -3.08% 50
15/26/15 €6.500 -1.52% 0
14/26/14 €6.600 0.00% 0
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.500EUR
Average target price
19.38EUR
Spread / Average Target
+198.08%

Annual profits - Rate of surprise